References
Alfageme I, Vazquez R, et al. Clinical efficacy
of anti-pneumococcal vaccination in patients with COPD. Thorax. 2006
Mar;61(3):189-95. Epub 2005 Oct 14.
Ansaldi F, Turello V, et al. Effectiveness of a 23-valent
polysaccharide vaccine in preventing pneumonia and non-invasive
pneumococcal infection in elderly people: a large-scale retrospective
cohort study. J Int Med Res. 2005 Sep-Oct;33(5):490-500.
Beckerman M, Magadle R, et al. The effects of 1 year of specific
inspiratory muscle training in patients with COPD. Chest. 2005
Nov;128(5):3177-82.
Bernkop-Schnurch A, Giovanelli R, et al. Peroral administration of
enzymes: Strategies to improve the galenic of dosage forms for trypsin
and bromelain. Drug Dev Ind Pharm. 2000 Feb;26(2):115–21.
Borghi-Silva A, Baldissera V, et al. L-carnitine as an ergogenic aid
for patients with chronic obstructive pulmonary disease submitted to
whole-body and respiratory muscle training programs. Braz J Med Biol
Res. 2006 Apr;39(4):465–74.
Brochard L. Mechanical ventilation: invasive versus noninvasive. Eur Respir J Suppl. 2003 Nov;47:31s-37s.
Business Wire. Weak Late Stage Pipeline Leaves Innovation to Phase
I/II Candidates. Business Wire. August 2004.
http://www.findarticles.com/p/articles/mi_m0EIN/is_2004_August_2/ai_n6136679.
Accessed May 19, 2006.
Calverley PM. Effect of corticosteroids on exacerbations of asthma
and chronic obstructive pulmonary disease. Proc Am Thorac Soc.
2004;1(3):161-6.
Chapkin RS, Hong MY, et al. Dietary n-3 PUFA alter colonocyte
mitochondrial membrane composition and function. Lipids. 2002
Feb;37(2):193–9.
Chorostowska-Wynimko J. [The beta2-adrenergic receptor agonists in
the treatment of chronic obstructive pulmonary disease]. Przegl Lek.
2005;62(7):724-8.
Cornuz J. Treating tobacco use and dependence in clinical practice. Expert Opin Pharmacother. 2006 Apr;7(6):783-92.
Daga MK, Chhabra R, et al. Effects of exogenous vitamin E
supplementation on the levels of oxidants and antioxidants in chronic
obstructive pulmonary disease. J Biosciences. February 2003;28(1):7–11.
Drost EM, Skwarski KM, et al. Oxidative stress and airway
inflammation in severe exacerbations of COPD. Thorax. 2005
Apr;60(4):293–300.
Ergas D, Eilat E, et al. N-3 fatty acids and the immune system in autoimmunity. Isr Med Assoc J. 2002 Jan;4(1):34–8.
Fernandes G, Chandrasekar B, et al. Modulation of antioxidant
enzymes and programmed cell death by n-3 fatty acids. Lipids. 1996;31
Suppl:S91–S96.
Fujimoto S, Kurihara N, et al. Effects of coenzyme Q10
administration on pulmonary function and exercise performance in
patients with chronic lung diseases. Clin Investig. 1993;71(8
Suppl):S162–S166.
Garrod R, Dallimore K, et al. An evaluation of the acute impact of
pursed lips breathing on walking distance in nonspontaneous pursed lips
breathing chronic obstructive pulmonary disease patients. Chron Respir
Dis. 2005;2(2):67-72.
Global Strategy for the Diagnosis, Management, and Prevention of
Chronic Obstructive Pulmonary Disease Executive Summary 2004.
http://www.guideline.gov/summary/summary.aspx?doc_id=8128. Accessed May
19, 2006.
Hind M, Maden M. Retinoic acid induces alveolar regeneration in the adult mouse lung. Eur Respir J. 2004 Jan;23(1):20–7.
Jaber R. Respiratory and allergic diseases: from upper respiratory
tract infections to asthma. Prim Care. 2002 Jun;29(2):231-61. Review.
Kasper DL, Braunwald E, et al. Harrison's Principles of Internal
Medicine. 16th ed. New York: McGraw-Hill Medical Publishing Division;
2005.
Kelly FJ. Vitamins and respiratory disease: Antioxidant
micronutrients in pulmonary health and disease. Proc Nutr Soc. 2005
Nov;64(4):510–26.
Kluchova Z, Petrasova D, et al. The association between oxidative
stress and obstructive lung impairment in patients with COPD. Physiol
Res. 2006 Feb 23.
Koumis T, Samuel S. Tiotropium bromide: a new long-acting
bronchodilator for the treatment of chronic obstructive pulmonary
disease. Clin Ther. 2005 Apr;27(4):377-92.
Lee P, Gildea TR, et al. Emphysema in nonsmokers: alpha
1-antitrypsin deficiency and other causes. Cleve Clin J Med. 2002
Dec;69(12):928-9, 933, 936 passim.
Lim TK. Treatment of severe exacerbation of chronic obstructive
pulmonary disease with mask-applied continuous positive airway
pressure. Respirology. 1996 Sep;1(3):189-93.
Maden M, Hind M. Retinoic acid in alveolar development, maintenance
and regeneration. Philos Trans R Soc Lond B Biol Sci. 2004 May
29;359(1445):799–808.
Mao JT, Goldin JG, et al. A pilot study of all-trans-retinoic acid
for the treatment of human emphysema. Am J Respir Crit Care Med. 2002
Mar 1;165(5):718–23.
Mao JT, Tashkin DP, et al. All-trans retinoic acid modulates the
balance of matrix metalloproteinase-9 and tissue inhibitor of
metalloproteinase-1 in patients with emphysema. Chest. 2003
Nov;124(5):1724–32.
Matsuyama W, Mitsuyama H, et al. Effects of omega-3 polyunsaturated
fatty acids on inflammatory markers in COPD. Chest. 2005
Dec;128(6):3817-27.
Meyers DA, Larj MJ, et al. Genetics of asthma and COPD. Similar
results for different phenotypes. Chest. 2004 Aug;126(2
Suppl):105S-110S; discussion 159S-161S. Review.
Nadeem A, Raj HG, et al. Increased oxidative stress and altered
levels of antioxidants in chronic obstructive pulmonary disease.
Inflammation. 2005 Feb;29(1):23–32.
Paiva SA, Goldoy I, et al. Assessment of vitamin A status in chronic
obstructive pulmonary disease patients and healthy smokers. Am J Clin
Nutr. 1996 Dec;64(6):928–34.
Pierson DJ. Clinical practice guidelines for chronic obstructive
pulmonary disease: a review and comparison of current resources. Respir
Care. 2006 Mar;51(3):277-88.
Rahman I, Biswas RK, et al. Oxidant and antioxidant balance in the
airways and airway diseases. Eur J Pharmacol. 2006 Mar
8;533(1-3):222–39.
Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev. 2001;23(2):268–87.
Schols A. Nutritional modulation as part of the integrated
management of chronic obstructive pulmonary disease. Proc Nutr Soc.
2003 Nov;62(4):783–91.
Shahar E, Folsom AR, et al. Dietary n-3 polyunsaturated fatty acids
and smoking-related chronic obstructive pulmonary disease.
Atherosclerosis Risk in Communities Study Investigators. N Engl J Med.
1994 Jul 28;331(4):228-33.
Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med. 2005 Apr;26(2):142–53.
Stey C, Steurer J, et al. The effect of oral N-acetylcysteine in
chronic bronchitis: A quantitative systematic review. Eur Resp J. 2000
Aug;16(2):253–62.
Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004 Jun 24;350(26):2689-97.
Tug T, Karatas F, et al. Antioxidant vitamins (A,C, and E) and
malondialdehyde levels in acute exacerbation and stable periods of
patients with chronic obstructive pulmonary disease. Clin & Inv
Med. June 2004;27(3):123–8.
Urbano FL, Pascual RM. Contemporary issues in the care of patients
with chronic obstructive pulmonary disease. J Manag Care Pharm. 2005
Jun;11(5 Suppl A):S2-13; quiz S14-6.
US National Library of Medicine. Genetics Home Reference: Alpha-1
antitrypsin deficiency 2005. Available at:
www.ghr.nlm.nih.gov/condition=alpha1antitrypsindeficiency. Accessed May
15, 2006
van Helvoort HA, Heijdra YF, et al. Supplemental Oxygen Prevents
Exercise-induced Oxidative Stress in Muscle-wasted Patients with
Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2006
May 15;173(10):1122-9. Epub 2006 Mar 2.
Vignola AM. PDE4 inhibitors in COPD: A more selective approach to treatment. Resp Med. June 2004;98(6):495–503.
Weder MM, Donohue JF. Role of bronchodilators in chronic obstructive
pulmonary disease. Semin Respir Crit Care Med. 2005 Apr;26(2):221-34.
Wijkstra PJ. Home based rehabilitation for patients with COPD. Is it
equally effective as compared to outpatient rehabilitation? Monaldi
Arch Chest Dis. 2003 Oct-Dec;59(4):335-7.
Zwick H, Lichtenschopf A. [COPD-rehabilitation]. Wien Med Wochenschr. 2005 Mar;155(5-6):101-5.
Print
PDF
Email
View Health Concern
